The relevance of increased MMP2 activity for prostate cancer cell invasion is underlined by the ability of the MMP2 inhibitor ARP100 to reduce the pro-invasive effects of DKK3-silenced WPMY-1 CM in PC3 cells. This evidence concerns the gene MMP2 and Familial prostate cancer.